The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

rddpharma.com

Stage

Merger | Merged

Total Raised

$17.93M

About RDD Pharma

RDD Pharma is a pharma company developing targeted pharmacological treatments for diseases of the anorectal region such as fecal incontinence and pruritus ani.On October 7th, 2019, RDD Pharma was merged with Innovate Biopharmaceuticals. The terms of the transaction were not disclosed.

RDD Pharma Headquarter Location

31 Habarzel St Ramat Hachayal

Tel Aviv, 69710,

Israel

+972 722419061

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing RDD Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

RDD Pharma is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

RDD Pharma Patents

RDD Pharma has filed 10 patents.

The 3 most popular patent topics include:

  • Beta blockers
  • Colorectal surgery
  • Digestive system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/21/2014

11/3/2020

Dosage forms, Drug delivery devices, Digestive system, Routes of administration, Pharmacokinetics

Grant

Application Date

4/21/2014

Grant Date

11/3/2020

Title

Related Topics

Dosage forms, Drug delivery devices, Digestive system, Routes of administration, Pharmacokinetics

Status

Grant

Latest RDD Pharma News

Global Transmucosal Drug Delivery Devices Pipeline Landscape Report 2021 - ResearchAndMarkets.com

Nov 2, 2021

3 Products under Development 3.2 Transmucosal Drug Delivery - Pipeline Products by Segment 3.3 Transmucosal Drug Delivery - Pipeline Products by Territory 3.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path 3.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date 3.6 Transmucosal Drug Delivery - Ongoing Clinical Trials 4 Transmucosal Drug Delivery - Pipeline Products under Development by Companies 4.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development 4.2 Transmucosal Drug Delivery - Pipeline Products by Stage of Development 5 Transmucosal Drug Delivery Companies and Product Overview 5.1 AcelRx Pharmaceuticals Inc Company Overview 5.2 AFYX Therapeutics A/S Company Overview 5.3 Albert Einstein College of Medicine Company Overview 5.4 Allergan Ltd Company Overview 5.5 Altamira Medica AG Company Overview 5.6 Amphastar Pharmaceuticals Inc Company Overview 5.7 Anelleo Inc Company Overview 5.8 APR Applied Pharma Research SA Company Overview 5.9 ARS Pharmaceuticals Inc Company Overview 5.10 Auris Medical AG Company Overview 5.11 Auritec Pharmaceuticals Inc Company Overview 5.12 Bayer Healthcare LLC Company Overview 5.13 BeFree! Company Overview 5.15 Biorings LLC Company Overview 5.16 BioXcel Therapeutics Inc Company Overview 5.17 Bryn Pharma LLC Company Overview 5.18 Callitas Therapeutics Inc Company Overview 5.19 Combinent BioMedical Systems Inc Company Overview 5.20 Conrad Company Overview 5.22 Eledon Pharmaceuticals Inc Company Overview 5.23 Emergent BioSolutions Inc Company Overview 5.24 Ena Respiratory Pty Ltd Company Overview 5.25 Eureka Therapeutics Inc Company Overview 5.26 Evestra Inc Company Overview 5.27 EyeGate Pharmaceuticals Inc Company Overview 5.28 Ferring Pharmaceuticals AS Company Overview 5.29 Ghent University Company Overview 5.30 Glenmark Pharmaceuticals Ltd Company Overview 5.31 Grunenthal Ltd Company Overview 5.32 Hebrew University of Jerusalem Company Overview 5.33 Hikma Pharmaceuticals Plc Company Overview 5.34 Insys Therapeutics Inc (Inactive) Company Overview 5.35 IntelGenx Corp Company Overview 5.36 ITF Pharma Inc Company Overview 5.37 Janssen Sciences Ireland UC Company Overview 5.38 Karessa Pharma AB Company Overview 5.39 Kytogenics Pharmaceuticals Inc Company Overview 5.40 Laboratoire HRA Pharma SAS Company Overview 5.41 Laboratorios Andromaco Company Overview 5.42 Lyra Therapeutics Inc Company Overview 5.43 McNeil AB Company Overview 5.44 Medlab Clinical Ltd Company Overview 5.45 Merck & Co Inc Company Overview 5.46 Merck Serono SA Company Overview 5.47 Merck Sharp & Dohme Ltd Company Overview 5.48 Mithra Pharmaceuticals SA Company Overview 5.49 Mucommune LLC Company Overview 5.50 Mystic Pharmaceuticals Inc Company Overview 5.51 Nanosys Inc Company Overview 5.52 Nasus Pharma Ltd Company Overview 5.53 Nemera La Verpilliere Company Overview 5.54 NorInvent AB Company Overview 5.55 Opiant Pharmaceuticals Inc Company Overview 5.56 OptiNose AS Company Overview 5.57 OptiNose Inc Company Overview 5.58 Orion Biotechnology Canada Ltd Company Overview 5.59 Orphanse Healthcare SAS Company Overview 5.60 Oyster Point Pharma Inc Company Overview 5.61 Palette Life Sciences AB Company Overview 5.62 Phoenix Life Sciences International Ltd Company Overview 5.63 RDD Pharma Ltd (Inactive) Company Overview 5.64 Renown Pharmaceuticals Pvt Ltd Company Overview 5.65 Rhinomed Limited Company Overview 5.66 Scientus Pharma Inc Company Overview 5.67 Seelos Therapeutics, Inc. Company Overview 5.68 Shin Nippon Biomedical Laboratories Ltd Company Overview 5.69 SipNose Ltd Company Overview 5.70 Starpharma Holdings Ltd Company Overview 5.71 Suda Pharmaceuticals Ltd Company Overview 5.72 Therakind Ltd Company Overview 5.73 University of Pittsburgh Company Overview 5.74 University of South Florida Company Overview 5.75 University of Texas at Austin Company Overview 5.76 University of the Witwatersrand Company Overview 5.77 University of Washington Company Overview 5.78 VistaGen Therapeutics Inc Company Overview 5.79 Washington University in St Louis Company Overview 5.80 Xlear Inc Company Overview 5.81 Zosano Pharma Corp Company Overview 5.82 Zydus Healthcare Ltd Company Overview 6 Transmucosal Drug Delivery- Recent Developments For more information about this report visit https://www.researchandmarkets.com/r/ib1dg3 Contacts

  • Where is RDD Pharma's headquarters?

    RDD Pharma's headquarters is located at 31 Habarzel St, Tel Aviv.

  • What is RDD Pharma's latest funding round?

    RDD Pharma's latest funding round is Merger.

  • How much did RDD Pharma raise?

    RDD Pharma raised a total of $17.93M.

  • Who are the investors of RDD Pharma?

    Investors of RDD Pharma include 9 Meters Biopharma, OrbiMed Advisors, Capital Point, Pharmascience and U.S. Department of Defense.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.